Introduction Uterine fibroids are the most common benign gynecological tumors affecting
women of reproductive ages. Although surgery is the definitive treatment choice, several …

Uterine fibroids are the most common benign neoplasm of the female reproductive tract in
reproductive age women. Their prevalence is age dependent and can be detected in up to …

Background Leiomyomas (fibroids), the most common benign solid tumours in females,
originate from the myometrium and are associated with poor quality of life for patients. The …

Objective Vilaprisan is a highly potent selective progesterone receptor modulator shown to
reduce heavy menstrual bleeding, induce amenorrhea, and diminish uterine fibroid volume …

Background Uterine fibroids constitute a significant health problem in the United States,
affecting upward of 11 million people. Objective Characterize the literature regarding the …

Introduction Uterine fibroids, the most prevalent benign tumors among reproductive-age
women, pose treatment challenges that range from surgical interventions to medical …

Abstract Objective To provide French guidelines for the management of women with
abnormal uterine bleeding (AUB). Design A consensus committee of 26 experts was formed …

Vilaprisan is a highly potent selective progesterone receptor modulator in development for
the treatment of symptomatic uterine fibroids and endometriosis. Its pharmacokinetics are …

Aims We report population pharmacokinetic (popPK) and exposure–response (E–R)
analyses for efficacy (induced amenorrhoea [IA]) and safety (unbound oestradiol [E2] …

Résumé Objectif Émettre des recommandations pour la prise en charge des femmes ayant
des ménorragies. Conception Un comité de 26 experts a été constitué. Une politique de …